N@N

Adaltis Inc.: Adaltis Announces Change to Board of Directors

^{Published on 2009-01-09 11:08:25, Last Modified on 2009-01-09 11:08:46 - Market Wire}
 

MONTREAL, QUEBEC--(Marketwire - Jan. 9, 2009) - Adaltis Inc. (TSX:ADS), an international in vitro diagnostic company, announced the resignation of Mr. Kwok Man Leung from the Board of Directors of the Company and as a member of the Audit Committee, effective December 31, 2008. The Board wishes to thank Mr. Kwok for his commitment to the Company.

About Adaltis Inc.

Adaltis is an international in vitro diagnostic company with a mission to become a leading provider of in vitro diagnostic products in emerging markets, with a particular focus on China.

With the strategic advantage of its "state of the art" reagent manufacturing facility located in Shanghai, China, a complete IVD product offering targeting emerging markets, and a strong international sales and distribution platform, Adaltis is able to manufacture high-quality products in a low-cost GMP environment, in order to service existing markets in Europe, while providing a platform to penetrate the high-growth Chinese in vitro diagnostic market.

Adaltis is headquartered in Montreal, with offices in China, Hong Kong, Italy, India and Mexico.